HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway.

Nat Commun · 2021 · PMC8602441 · PMID 34795269

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

Enrichment analysis of the PI3K/AKT pathway in metastatic samples did not reach statistical significance ( p = 0.07; OR 1.37 [0.97−1.84]).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.